Utility of the phaseal closed system drug transfer device

American Journal of Pharmacy Benefits

Volumn 3, Issue 1, 2011, Pages 9-16

  McMichael, Derek M ^a   Jefferson, Dawn Moore ^a   Carey, E Thomas ^b   Forrey, Ryan A ^c   Spivey, Susan M ^d   Mulvaney, John M ^e   Jorgenson, James A ^a   Douglas Haughs, R ^f  

^a INDIANA UNIVERSITY   (United States)

^b Swedish American Hospital   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e BUTLER UNIVERSITY   (United States)

^f Bio Med QC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASEPSIS; BACTERIUM CULTURE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; MECHANICS; MICROBIAL CONTAMINATION; MICROSCOPY; QUALITY CONTROL; SYRINGE;

EID: 79951475821     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Pear R. Health care spending rises in 2008, but at slower rate. New York Times. January 4, 2010.
2. Truffer CJ, Keehan S, Smith S, et al. Health spending projections through 2019: the recession's impact continues. Health Aff (Millwood). 2010;29(3):522-529.
3. Wilson AL, American Society for Health-System Pharmacists. Financial Management for Health-System Pharmacists. Bethesda, MD: American Society for Health-System Pharmacists; 2009.
4. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151-185.
5. US Pharmacopeia. USP <797> Guidebook to Pharmaceutical Compounding - Sterile Product Preparations. Rockville, MD: United States Pharmacopeial Convention; 2008. http://www.usp.org/products/797Guidebook/. Accessed January 5, 2011.
6. National Institute for Occupational Safety and Health. NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Atlanta, GA: NIOSH; September 2004. NIOSH publication 2004-165. http://www.cdc.gov/niosh/docs/2004-165/. Accessed January 5, 2011.
7. American Society for Health-System Pharmacists. Continuing education: ASHP guidelines for handling hazardous drugs. Am J Health Syst Pharm. 2006;63:1172-1191.
8. International Society of Oncology Pharmacy Practitioners Standards Committee. ISOPP standards of practice: safe handling of cytotoxics. J Oncol Pharm Pract. 2007;13(suppl):1-81.
9. Jorgenson J, Spivey S, Au C, et al. Contamination comparison of transfer devices intended for handling hazardous drugs. Hosp Pharm. 2008;43(9):723-727.
10. Spivey S, Connor T. Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm. 2003;38(2):135-139.
11. Nygren O, Gustavsson B, Ström L, Eriksson R, Jarneborn L, Friberg A. Exposure to anti-cancer drugs during preparation and administration: investigation of an open and closed system. J Environ Monit. 2002;4(5):739-742.
12. De Prijck K, D'Haese E, Vandenbroucke J, Coucke W, Robays H, Nelis HJ. Microbiological challenge of four protective devices for the reconstitution of cytotoxic agents. Lett Appl Microbiol. 2008;47(6):543-548.